×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Cardiac Implants Market Analysis

ID: MRFR/MED/5263-CR
163 Pages
Rahul Gotadki
April 2019

Cardiac Implants Market Research Report Information by Device (Coronary Stents, Prosthetic Heart Valve Devices, & Others), Indication (Arrhythmias, Heart Failure, & Others), End User (Hospitals, Cardiac Care Centers, & Others), and Region - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Cardiac Implants Market Infographic
×
Cardiac Implants Market Infographic Full View
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Cardiac Implants Market Industry Landscape

Compression therapy is a clinical intervention that involves applying managed pressure to precise frame components and the usage of clothes like stockings or bandages. The market dynamics of Compression therapy are encouraged by the growing prevalence of chronic diseases, which include venous insufficiency and diabetes. As those situations turn out to be extra enormous, there may be a developing demand for effective and non-invasive treatments like compression therapy to manipulate signs and improve affected persons' effects. The Compression therapy marketplace has accelerated beyond scientific applications to the sports activities and fitness industry. Athletes use compression garments to enhance performance, lessen muscle fatigue, and accelerate restoration. This diversification broadens the client base and influences market dynamics. The developing emphasis on preventive healthcare and well-being developments contributes to the marketplace dynamics. Compression therapy is increasingly diagnosed as a safety measure in opposition to certain situations, attractive to folks who prioritize maintaining the highest quality fitness and well-being. Market dynamics are stimulated by attention campaigns and academic projects highlighting the benefits of Compression therapy. Healthcare professionals and producers interact in efforts to inform both patients and the public about the healing advantages of compression clothes. The rise of e-trade systems has transformed the distribution channels for Compression therapy merchandise. Consumers can now, without difficulty, get entry to compression clothes online due to expanded marketplace competition and the emergence of direct-to-consumer income fashions. The market responds to the developing demand for personalized healthcare answers. Manufacturers are growing customizable compression clothes that cater to character patient desires, considering factors including length, compression stage, and particular clinical conditions. Adherence to regulatory standards and first-class assurance is important within the Compression therapy market. Manufacturers need to follow guidelines to ensure the safety and effectiveness of their products, influencing market dynamics and shaping patron acceptance as true. The globalization of healthcare and increasing admission to scientific treatments globally impact market dynamics. As the focus of compression therapy spreads globally, the marketplace stories enlarge into new areas, using the need to adapt to diverse healthcare landscapes. The effectiveness of compression therapy is predicated on patient compliance, and market dynamics are motivated by demanding situations on this element. Manufacturers and healthcare experts work on growing user-pleasant and comfortable compression clothes to improve adherence to remedy plans. Insurance and compensation rules considerably impact marketplace dynamics. Changes in healthcare policies and the multiplied popularity of Compression therapy as a reimbursable treatment alternative impact the affordability and accessibility of these interventions for sufferers.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the valuation of the Cardiac Implants Market?

Cardiac implants market is expected to rise to a valuation of more than USD 97.13 Billion by 2032.

What is the CAGR of the Cardiac Implants Market?

The global market is expected to exhibit a strong 9.82% CAGR over the forecast period.

What is the prime driver for the market?

The increasing geriatric population and the increasing prevalence of chronic heart conditions are the major drivers for the global cardiac implants market.

What is the key restraint on the Cardiac Implants Market?

The high costs of cardiac implants are the key restraint against the global cardiac implants market.

What is the leading regional segment of the Cardiac Implants Market?

North America is likely to hold the largest share in the global cardiac implants market.

Market Summary

As per MRFR analysis, the Cardiac Implants Market Size was estimated at 46.43 USD Billion in 2024. The Cardiac Implants industry is projected to grow from 50.0 in 2025 to 93.79 by 2035, exhibiting a compound annual growth rate (CAGR) of 6.56 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Cardiac Implants Market is poised for substantial growth driven by technological advancements and increasing healthcare demands.

  • North America remains the largest market for cardiac implants, driven by advanced healthcare infrastructure and high patient awareness.
  • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and a burgeoning population.
  • Coronary artery disease continues to dominate the market, while the arrhythmia segment is experiencing rapid growth due to increasing diagnosis rates.
  • Technological advancements and the growing prevalence of cardiovascular diseases are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 46.43 (USD Billion)
2035 Market Size 93.79 (USD Billion)
CAGR (2025 - 2035) 6.56%
Largest Regional Market Share in 2024 North America

Major Players

<p>Medtronic (US), Abbott (US), Boston Scientific (US), Edwards Lifesciences (US), Biotronik (DE), LivaNova (GB), St. Jude Medical (US), Cardinal Health (US), Terumo (JP)</p>

Market Trends

The Cardiac Implants Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing prevalence of cardiovascular diseases. Innovations in implantable devices, such as pacemakers and defibrillators, are enhancing patient outcomes and improving quality of life. Furthermore, the integration of telemedicine and remote monitoring systems is reshaping how healthcare providers manage cardiac patients, allowing for timely interventions and personalized care. This shift towards more patient-centric approaches appears to be a key factor in the market's growth, as stakeholders seek to address the rising demand for effective cardiac solutions. In addition, the Cardiac Implants Market is witnessing a surge in research and development activities aimed at creating next-generation devices. These innovations may include bioresorbable implants and advanced materials that reduce the risk of complications. Regulatory bodies are also playing a crucial role in ensuring the safety and efficacy of these products, which could further bolster market confidence. As the landscape evolves, collaboration among manufacturers, healthcare providers, and regulatory agencies seems essential to navigate the complexities of this dynamic market.

Technological Advancements

The Cardiac Implants Market is significantly influenced by rapid technological advancements. Innovations in device design, materials, and functionalities are enhancing the performance and safety of cardiac implants. These developments not only improve patient outcomes but also expand the range of treatable conditions, thereby increasing the market's potential.

Growing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases is a major driver of the Cardiac Implants Market. As more individuals are diagnosed with heart-related conditions, the demand for effective treatment options, including various cardiac implants, is likely to increase. This trend underscores the urgent need for innovative solutions to address this public health challenge.

Regulatory Support and Collaboration

Regulatory bodies are increasingly supporting the development and approval of new cardiac implant technologies. Collaborative efforts between manufacturers and healthcare providers are fostering an environment conducive to innovation. This synergy may lead to the introduction of safer and more effective devices, ultimately benefiting patients and healthcare systems.

Cardiac Implants Market Market Drivers

Market Growth Projections

The Global Cardiac Implants Market Industry is projected to experience substantial growth in the coming years. With a compound annual growth rate (CAGR) of 9.82% anticipated from 2025 to 2035, the market is expected to expand significantly. By 2024, the market is estimated to reach 44.9 USD Billion, and by 2035, it could potentially reach 125.7 USD Billion. This growth trajectory reflects the increasing demand for cardiac implants driven by various factors, including technological advancements, an aging population, and rising healthcare expenditures. The market's expansion indicates a robust future for cardiac health solutions.

Regulatory Support and Reimbursement Policies

Supportive regulatory frameworks and favorable reimbursement policies are pivotal in shaping the Global Cardiac Implants Market Industry. Governments and health authorities are increasingly recognizing the importance of cardiac implants in managing heart diseases, leading to streamlined approval processes for new devices. Additionally, comprehensive reimbursement policies facilitate access to these technologies, encouraging healthcare providers to adopt them. This supportive environment fosters innovation and investment in the development of advanced cardiac implants. Consequently, the market is poised for growth, as these factors collectively enhance the accessibility and affordability of cardiac care.

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases globally is a primary driver of the Global Cardiac Implants Market Industry. As lifestyle-related factors such as obesity, sedentary behavior, and unhealthy diets continue to escalate, the demand for cardiac implants is likely to increase. For instance, cardiovascular diseases account for approximately 31% of all global deaths, highlighting the urgent need for effective treatment options. This growing health crisis is expected to propel the market, which is projected to reach 44.9 USD Billion in 2024, indicating a robust demand for innovative cardiac solutions.

Technological Advancements in Implantable Devices

Technological innovations in implantable cardiac devices are transforming the Global Cardiac Implants Market Industry. Advancements such as bioresorbable stents, leadless pacemakers, and remote monitoring capabilities enhance the efficacy and safety of cardiac implants. These innovations not only improve patient outcomes but also reduce the risk of complications, thereby increasing adoption rates among healthcare providers. The integration of artificial intelligence and machine learning into these devices further personalizes treatment, potentially leading to better management of cardiovascular conditions. As a result, the market is anticipated to experience significant growth, driven by these cutting-edge technologies.

Aging Population and Increased Healthcare Expenditure

The global demographic shift towards an aging population is a crucial factor influencing the Global Cardiac Implants Market Industry. Older adults are more susceptible to cardiovascular diseases, necessitating advanced medical interventions such as cardiac implants. Additionally, increased healthcare expenditure in many countries supports the adoption of these technologies. Governments and healthcare systems are investing in innovative treatments to address the growing burden of heart diseases. This trend is expected to contribute to the market's expansion, with projections indicating a growth trajectory that could see the market reach 125.7 USD Billion by 2035.

Rising Awareness and Preventive Healthcare Initiatives

Growing awareness regarding cardiovascular health and preventive healthcare initiatives are driving the Global Cardiac Implants Market Industry. Educational campaigns and community outreach programs are informing the public about the risks associated with heart diseases and the benefits of early intervention. This heightened awareness encourages individuals to seek medical advice and treatment, leading to increased demand for cardiac implants. Furthermore, healthcare providers are emphasizing preventive measures, which may result in earlier diagnoses and timely interventions. As a consequence, the market is likely to witness sustained growth as more patients opt for cardiac implants as a preventive measure.

Market Segment Insights

By Application: Coronary Artery Disease (Largest) vs. Arrhythmia (Fastest-Growing)

<p>The Cardiac Implants Market is significantly influenced by its application segments, with Coronary Artery Disease (CAD) accounting for the largest share. CAD is a major contributor to the prevalence of cardiac implants, as it requires interventions such as stents and bypass grafts. Following closely behind are other conditions like Heart Valve Disease and Heart Failure, which also command a substantial market share thanks to aging populations and an increase in chronic diseases. Arrhythmia, while smaller, is growing rapidly as awareness and technological advancements make treatment more accessible.</p>

<p>Coronary Artery Disease (Dominant) vs. Arrhythmia (Emerging)</p>

<p>Coronary Artery Disease remains the dominant application in the Cardiac Implants Market, primarily due to the high incidence rates and the need for complex interventions. Various devices, including drug-eluting stents and coronary artery bypass grafts, play a crucial role in treating this condition. Meanwhile, the Arrhythmia segment is emerging robustly, driven by innovations in cardiac monitoring and ablation technologies. This segment benefits from a rising pool of patients, improved diagnostic tools, and dedicated devices like pacemakers and implantable cardioverter-defibrillators (ICDs). The urgency in treatment for arrhythmia conditions is fostering rapid growth, indicative of a shift towards preventive and timely interventions in cardiology.</p>

By Type of Implant: Pacemakers (Largest) vs. Implantable Cardioverter Defibrillators (Fastest-Growing)

<p>The Cardiac Implants Market demonstrates a diverse range of devices, with pacemakers holding the largest market share due to their widespread adoption in managing bradycardia and heart block conditions. Following pacemakers, implantable cardioverter defibrillators (ICDs) are gaining traction, driven by their crucial role in preventing sudden cardiac arrests. Together, these two segments capture significant attention from healthcare providers and patients, influencing advanced product development and market competitiveness.</p>

<p>Pacemakers (Dominant) vs. Implantable Cardioverter Defibrillators (Emerging)</p>

<p>Pacemakers have established themselves as the dominant segment within the Cardiac Implants Market, primarily used for managing arrhythmias and facilitating heart rhythm control. Their proven efficacy and increasing recognition drive market demand, supported by advancements in technology that enhance pacemaker functionality and patient comfort. On the other hand, implantable cardioverter defibrillators (ICDs) represent an emerging segment, rapidly growing in response to increased awareness about sudden cardiac arrest prevention. Innovations in device design and automatic monitoring capabilities make ICDs increasingly attractive to both physicians and patients, creating new opportunities within the cardiac care landscape.</p>

By End User: Hospitals (Largest) vs. Cardiac Clinics (Fastest-Growing)

<p>In the Cardiac Implants Market, hospitals hold the largest market share due to their comprehensive range of services and advanced facilities for managing cardiac patients. They are equipped with state-of-the-art technology and offer a wide array of cardiac procedures, which significantly contributes to their dominance in this segment. Conversely, cardiac clinics are rapidly gaining traction, especially as they specialize in personalized care for patients with cardiac issues, making them a preferred choice for many individuals seeking targeted treatments. The growth trends in the Cardiac Implants Market are being propelled by various factors. Hospitals benefit from their established infrastructure and collaboration with leading implant manufacturers, enabling them to stay at the forefront of cardiac care. In contrast, cardiac clinics are becoming the fastest-growing segment due to rising consumer preferences for specialized clinics that focus exclusively on cardiac conditions, thereby providing efficient, customized care that is often more accessible and less intimidating than hospital settings.</p>

<p>Hospitals (Dominant) vs. Home Care Settings (Emerging)</p>

<p>Hospitals remain the dominant force in the Cardiac Implants Market, primarily due to their ability to provide intensive care, advanced surgical interventions, and comprehensive treatment plans. These facilities not only offer the latest implant technologies but also have the resources to support patients with complex needs. Meanwhile, home care settings are emerging as a viable alternative, driven by advances in telehealth technology and the increasing emphasis on patient-centered care. These settings enable patients to recover in the comfort of their homes while still receiving necessary monitoring and support, often leading to better patient satisfaction and outcomes. As healthcare evolves, the integration of home care solutions into the cardiac care continuum reflects a significant shift towards more personalized and accessible healthcare approaches.</p>

Get more detailed insights about Cardiac Implants Market Research Report - Global Forecast till 2035

Regional Insights

North America : Market Leader in Innovation

North America continues to lead the cardiac implants market, holding a significant share of 23.5% in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of cardiovascular diseases, and a strong focus on research and development. Regulatory support from agencies like the FDA further catalyzes innovation, ensuring rapid approval of new technologies and devices. The competitive landscape is robust, with key players such as Medtronic, Abbott, and Boston Scientific dominating the market. The U.S. remains the largest contributor, benefiting from high healthcare expenditure and a well-established distribution network. The presence of leading companies fosters a dynamic environment for technological advancements, ensuring that North America remains at the forefront of cardiac implant innovations.

Europe : Emerging Market with Growth Potential

Europe's cardiac implants market is valued at €12.5 billion, reflecting a growing demand for advanced cardiac care solutions. Factors such as an aging population, rising healthcare investments, and increasing awareness of cardiovascular health are driving this growth. Regulatory frameworks in the EU are becoming more supportive, facilitating quicker access to innovative treatments and devices. Leading countries like Germany, France, and the UK are pivotal in this market, with a strong presence of companies like Biotronik and LivaNova. The competitive landscape is characterized by collaborations and partnerships aimed at enhancing product offerings. As the market evolves, Europe is poised to become a significant player in the global cardiac implants sector, focusing on patient-centric solutions and technological advancements.

Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific region, with a market size of $8.0 billion, is witnessing rapid growth in the cardiac implants sector. This growth is fueled by rising disposable incomes, increasing healthcare access, and a growing prevalence of heart diseases. Governments are investing in healthcare infrastructure, which is enhancing the availability of advanced medical technologies. Regulatory bodies are also streamlining approval processes to encourage innovation. Countries like Japan, China, and India are leading the charge, with significant contributions from local and international players. Companies such as Terumo and Abbott are expanding their footprint in this region, focusing on tailored solutions to meet diverse healthcare needs. The competitive landscape is evolving, with a mix of established firms and emerging startups driving innovation and market growth.

Middle East and Africa : Untapped Market with Potential

The Middle East and Africa region, valued at $2.43 billion, presents an untapped market for cardiac implants. The growth is driven by increasing awareness of cardiovascular diseases, improving healthcare infrastructure, and rising investments in medical technology. Governments are prioritizing healthcare reforms, which are expected to enhance access to cardiac care solutions. Countries like South Africa and the UAE are at the forefront, with a growing number of healthcare facilities adopting advanced cardiac technologies. The competitive landscape is gradually evolving, with both local and international players seeking to establish a presence. As the region continues to develop, opportunities for growth in the cardiac implants market are becoming increasingly apparent, paving the way for innovative solutions.

Key Players and Competitive Insights

The Cardiac Implants Market is characterized by a dynamic competitive landscape, driven by technological advancements, an aging population, and increasing prevalence of cardiovascular diseases. Major players such as Medtronic (US), Abbott (US), and Boston Scientific (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Medtronic (US) focuses on innovation through extensive R&D investments, while Abbott (US) emphasizes strategic partnerships to expand its product offerings. Boston Scientific (US) appears to be concentrating on regional expansion, particularly in emerging markets, thereby shaping a competitive environment that is increasingly collaborative yet fiercely competitive.

In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is crucial in a moderately fragmented market. The collective influence of these key players is significant, as they not only drive technological advancements but also set industry standards that smaller firms must adhere to. This competitive structure fosters an environment where innovation is paramount, and companies are compelled to differentiate themselves through unique offerings and operational efficiencies.

In November 2025, Medtronic (US) announced the launch of its next-generation cardiac monitor, which integrates advanced AI algorithms for real-time data analysis. This strategic move is likely to enhance patient outcomes by providing healthcare professionals with timely insights, thereby reinforcing Medtronic's commitment to innovation and patient-centric solutions. The introduction of such technology may also position the company favorably against competitors who are yet to adopt similar advancements.

In October 2025, Abbott (US) entered into a partnership with a leading telehealth provider to enhance remote patient monitoring capabilities. This collaboration is strategically significant as it aligns with the growing trend of digital health solutions, allowing Abbott to leverage telehealth technologies to improve patient engagement and adherence to treatment plans. Such initiatives may not only expand Abbott's market reach but also enhance its reputation as a leader in integrated healthcare solutions.

In September 2025, Boston Scientific (US) completed the acquisition of a European cardiac device manufacturer, which is expected to bolster its product portfolio and market presence in Europe. This acquisition reflects a strategic focus on expanding geographical reach and diversifying product offerings, which could provide Boston Scientific with a competitive edge in a rapidly evolving market.

As of December 2025, current trends in the Cardiac Implants Market indicate a strong emphasis on digitalization, sustainability, and AI integration. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise to drive innovation. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and sustainable practices. This shift suggests that companies that prioritize innovation and adaptability will be better positioned to thrive in the future.

Key Companies in the Cardiac Implants Market include

Industry Developments

  • Q2 2024: Medtronic receives FDA approval for next-generation Micra AV2 and Micra VR2 leadless pacemakers Medtronic announced that the U.S. FDA has approved its latest Micra AV2 and Micra VR2 leadless pacemakers, expanding options for patients needing cardiac rhythm management devices.
  • Q2 2024: Boston Scientific launches FARAPULSE Pulsed Field Ablation System in Europe Boston Scientific announced the commercial launch of its FARAPULSE Pulsed Field Ablation System for the treatment of atrial fibrillation in select European markets following CE Mark approval.
  • Q1 2024: Edwards Lifesciences receives FDA approval for SAPIEN 3 Ultra RESILIA heart valve Edwards Lifesciences announced U.S. FDA approval of its SAPIEN 3 Ultra RESILIA valve, a next-generation transcatheter heart valve designed to improve durability and patient outcomes.
  • Q2 2024: Abbott launches AVEIR DR dual chamber leadless pacemaker system in the U.S. Abbott announced the U.S. launch of its AVEIR DR dual chamber leadless pacemaker system, the first of its kind to receive FDA approval for treating patients with abnormal heart rhythms.
  • Q1 2024: Biotronik receives CE Mark for BIOMONITOR IV implantable cardiac monitor Biotronik announced it has received CE Mark approval for its BIOMONITOR IV, an implantable cardiac monitor designed for long-term heart rhythm monitoring.
  • Q2 2024: Boston Scientific completes $3.7 billion acquisition of Axonics Boston Scientific finalized its acquisition of Axonics, a company specializing in implantable sacral neuromodulation devices, expanding its portfolio in the cardiac and urology device markets.
  • Q1 2024: Medtronic launches Harmony Transcatheter Pulmonary Valve in Japan Medtronic announced the commercial launch of its Harmony Transcatheter Pulmonary Valve in Japan, following regulatory approval for use in patients with congenital heart disease.
  • Q2 2024: Abbott receives FDA approval for TriClip transcatheter tricuspid valve repair system Abbott announced that the U.S. FDA has approved its TriClip system, the first transcatheter device for repairing the tricuspid heart valve, offering a new treatment option for patients with tricuspid regurgitation.
  • Q1 2024: LivaNova appoints new CEO, Vladimir Makatsaria LivaNova, a global medical technology company specializing in cardiac surgery and neuromodulation, announced the appointment of Vladimir Makatsaria as its new Chief Executive Officer.
  • Q2 2024: Edwards Lifesciences opens new manufacturing facility in Ireland Edwards Lifesciences inaugurated a new manufacturing facility in Limerick, Ireland, to expand production capacity for its transcatheter heart valve technologies.
  • Q1 2024: CardioFocus receives FDA approval for HeartLight X3 Endoscopic Ablation System CardioFocus announced that the U.S. FDA has approved its HeartLight X3 Endoscopic Ablation System for the treatment of atrial fibrillation, enhancing options for minimally invasive cardiac procedures.
  • Q2 2024: Boston Scientific receives FDA approval for WATCHMAN FLX Pro Left Atrial Appendage Closure Device Boston Scientific announced U.S. FDA approval of its WATCHMAN FLX Pro device, designed to reduce stroke risk in patients with non-valvular atrial fibrillation.

.

Future Outlook

Cardiac Implants Market Future Outlook

<p>The Cardiac Implants Market is projected to grow at a 6.56% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of cardiac diseases, and rising healthcare expenditure.</p>

New opportunities lie in:

  • <p>Development of AI-driven predictive analytics for patient monitoring</p>
  • <p>Expansion of telehealth services for remote cardiac care</p>
  • <p>Investment in biodegradable cardiac devices for sustainable solutions</p>

<p>By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.</p>

Market Segmentation

Cardiac Implants Market End User Outlook

  • Hospitals
  • Cardiac Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

Cardiac Implants Market Application Outlook

  • Coronary Artery Disease
  • Heart Valve Disease
  • Arrhythmia
  • Heart Failure
  • Congenital Heart Defects

Cardiac Implants Market Type of Implant Outlook

  • Pacemakers
  • Implantable Cardioverter Defibrillators
  • Cardiac Resynchronization Therapy Devices
  • Heart Valves
  • Stents

Report Scope

MARKET SIZE 202446.43(USD Billion)
MARKET SIZE 202550.0(USD Billion)
MARKET SIZE 203593.79(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)6.56% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMedtronic (US), Abbott (US), Boston Scientific (US), Edwards Lifesciences (US), Biotronik (DE), LivaNova (GB), St. Jude Medical (US), Cardinal Health (US), Terumo (JP)
Segments CoveredApplication, Type of Implant, End User
Key Market OpportunitiesIntegration of advanced biomaterials and digital health technologies in the Cardiac Implants Market.
Key Market DynamicsTechnological advancements and regulatory changes drive innovation and competition in the cardiac implants market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

What is the valuation of the Cardiac Implants Market?

Cardiac implants market is expected to rise to a valuation of more than USD 97.13 Billion by 2032.

What is the CAGR of the Cardiac Implants Market?

The global market is expected to exhibit a strong 9.82% CAGR over the forecast period.

What is the prime driver for the market?

The increasing geriatric population and the increasing prevalence of chronic heart conditions are the major drivers for the global cardiac implants market.

What is the key restraint on the Cardiac Implants Market?

The high costs of cardiac implants are the key restraint against the global cardiac implants market.

What is the leading regional segment of the Cardiac Implants Market?

North America is likely to hold the largest share in the global cardiac implants market.

  1. Report Prologue 2 Market Introduction
    1. Definition 17
    2. Scope of Study 17
    3. List of Assumptions 17
    4. Market Structure 18 3 Research Methodology
    5. Research Process 20
    6. Primary Research 21
    7. Secondary Research 22
    8. Market Size Estimation 23
    9. Forecast Model 23 4 Market Dynamics
    10. Overview 25
    11. Drivers 26
      1. Rising prevalence of cardiac diseases 26
      2. Increasing geriatric population 26
    12. Restraints 26
      1. High cost of cardiac implants 26
      2. Risk of infection due to cardiac implants 27
    13. Opportunities 27
      1. Technological advancements in cardiac implants 27 5 Market Factor Analysis
    14. Value Chain Analysis 29
      1. R&D and Designing 29
      2. Manufacturing 29
      3. Distribution & Sales 29
      4. Post-Sales Review 29
    15. Porter’s Five Forces Model 30
      1. Bargaining Power of Suppliers 30
      2. Bargaining Power of Buyers 31
      3. Threat of New Entrants 31
      4. Threat of Substitutes 31
      5. Intense Rivalry 31
    16. Investment Opportunities 31
    17. Pricing Analysis 32 6 Cardiac Implants Market, by Device
    18. Overview 34
    19. Cardiac Rhythm Management Devices 35
    20. Coronary Stents 37
    21. Prosthetic Heart Valve Devices 38
    22. Ventricular Assist Devices 39
    23. Implantable Loop Recorder/Implantable Cardiac Monitor 40
    24. Others 40 7 Global Cardiac Implants Market, by Indication
    25. Overview 42
    26. Arrhythmias 43
    27. Myocardial Ischemia 44
    28. Acute Myocardial Infarction 44
    29. Heart Failure 45
    30. Others 46 8 Cardiac Implants Market, by End User
    31. Overview 48
    32. Hospitals 49
    33. Cardiac Care Centers 50
    34. Ambulatory Centers & Home Care 50
    35. Academic Institutes 51
    36. Others 51 9 Global Cardiac Implants Market, by Region
    37. Overview 53
    38. Americas 55 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      1. North America 59 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      2. Latin America 69 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
    39. Europe 73 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      1. Western Europe 77 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      2. Eastern Europe 99 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
    40. Asia-Pacific 103 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      1. Japan 107 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      2. China 110 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      3. India 113 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      4. Australia 116 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      5. South Korea 119 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      6. Rest of Asia-Pacific 122 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
    41. Middle East & Africa 126 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      1. Middle East 130 Cardiac Implants Market, by Device Cardiac Implants Market, by End User
      2. Africa 133 Cardiac Implants Market, by Device Cardiac Implants Market, by End User 10 Competitive Landscape
    42. Introduction 138 11 Company Profile
    43. Abbott 140
      1. Company Overview 140
      2. Financial Overview 140
      3. Products/Services Offered 140
      4. SWOT Analysis 141
      5. Key Developments 141
      6. Key Strategy 141
    44. Amg International 142
      1. Company Overview 142
      2. Financial Overview 142
      3. Products/Services Offered 142
      4. SWOT Analysis 142
      5. Key Developments 142
      6. Key Strategy 142
    45. Edwards Lifesciences Corporation 143
      1. Company Overview 143
      2. Financial Overview 143
      3. Products/Services Offered 144
      4. Key Developments 144
      5. SWOT Analysis 145
      6. Key Strategy 145
    46. B. Braun Melsungen AG 146
      1. Company Overview 146
      2. Financial Overview 146
      3. Products/Services Offered 146
      4. SWOT Analysis 147
      5. Key Developments 147
      6. Key Strategy 147
    47. Biotronik 148
      1. Company Overview 148
      2. Financial Overview 148
      3. Products/Services Offered 148
      4. SWOT Analysis 149
      5. Key Developments 149
      6. Key Strategy 149
    48. Boston Scientific Corporation 150
      1. Company Overview 150
      2. Financial Overview 150
      3. Products/Services Offered 151
      4. Key Developments 151
      5. SWOT Analysis 152
      6. Key Strategy 152
    49. LivaNova PLC 153
      1. Company Overview 153
      2. Financial Overview 153
      3. Products/Services Offered 153
      4. Key Developments 154
      5. SWOT Analysis 154
      6. Key Strategy 154
    50. Medtronic Plc 155
      1. Company Overview 155
      2. Financial Overview 155
      3. Products/Services Offered 156
      4. Key Developments 157
      5. SWOT Analysis 157
      6. Key Strategy 157
    51. SynCardia Systems, Inc. 158
      1. Company Overview 158
      2. Financial Overview 158
      3. Products/Services Offered 158
      4. Key Developments 158
      5. SWOT Analysis 158
      6. Key Strategy 158
    52. Terumo Corporation 159
      1. Company Overview 159
      2. Financial Overview 159
      3. Products/Services Offered 159
      4. Key Developments 160
      5. SWOT Analysis 160
      6. Key Strategy 160
  2. Appendix
    1. Discussion Blue Print 162 15 List of Tables
  3. LIST OF ASSUMPTIONS 17
  4. GLOBAL CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 35
  5. GLOBAL CARDIAC IMPLANTS MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES, BY REGION, 2022–2030 (USD Billion) 36
  6. GLOBAL CARDIAC IMPLANTS MARKET FOR CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 36
  7. GLOBAL CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 36
  8. GLOBAL CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY REGION, 2022–2030 (USD Billion) 37
  9. GLOBAL CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 37
  10. GLOBAL CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY REGION, 2022–2030 (USD Billion) 38
  11. GLOBAL CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 39
  12. GLOBAL CARDIAC IMPLANTS MARKET FOR VENTRICULAR ASSIST DEVICES, BY REGION, 2022–2030 (USD Billion) 39
  13. GLOBAL CARDIAC IMPLANTS MARKET FOR IMPLANTABLE LOOP RECORDER/IMPLANTABLE CARDIAC MONITOR, BY REGION, 2022–2030 (USD Billion) 40
  14. GLOBAL CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 43
  15. GLOBAL CARDIAC IMPLANTS MARKET FOR ARRHYTHMIAS, BY REGION, 2022–2030 (USD Billion) 43
  16. GLOBAL CARDIAC IMPLANTS MARKET FOR MYOCARDIAL ISCHEMIA, BY REGION, 2022–2030 (USD Billion) 44
  17. GLOBAL CARDIAC IMPLANTS MARKET FOR ACUTE MYOCARDIAL INFARCTION, BY REGION, 2022–2030 (USD Billion) 45
  18. GLOBAL CARDIAC IMPLANTS MARKET FOR HEART FAILURE, BY REGION, 2022–2030 (USD Billion) 45
  19. GLOBAL CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 49
  20. GLOBAL CARDIAC IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2022–2030 (USD Billion) 49
  21. GLOBAL CARDIAC IMPLANTS MARKET FOR CARDIAC CARE CENTERS, BY REGION, 2022–2030 (USD Billion) 50
  22. GLOBAL CARDIAC IMPLANTS MARKET FOR AMBULATORY CENTERS & HOME CARE, BY REGION, 2022–2030 (USD Billion) 50
  23. GLOBAL CARDIAC IMPLANTS MARKET FOR ACADEMIC INSTITUTES, BY REGION, 2022–2030 (USD Billion) 51
  24. GLOBAL CARDIAC IMPLANTS MARKET, BY REGION, 2022–2030 (USD Billion) 54
  25. AMERICAS: CARDIAC IMPLANTS MARKET, BY REGION, 2022–2030 (USD Billion) 55
  26. AMERICAS: CARDIAC IMPLANTS MARKET, BY DEVICES, 2022–2030 (USD Billion) 56
  27. AMERICAS: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 56
  28. AMERICAS: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 57
  29. AMERICAS: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 57
  30. AMERICAS: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 58
  31. AMERICAS: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 58
  32. AMERICAS: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 59
  33. NORTH AMERICA: CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD Billion) 59
  34. NORTH AMERICA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 60
  35. NORTH AMERICA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 60
  36. NORTH AMERICA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 61
  37. NORTH AMERICA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 61
  38. NORTH AMERICA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 62
  39. NORTH AMERICA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 62
  40. NORTH AMERICA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 63
  41. US: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 63
  42. US: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 64
  43. US: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 64
  44. US: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 64
  45. US: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 65
  46. US: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 65
  47. US: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 66
  48. CANADA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 66
  49. CANADA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 67
  50. CANADA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 67
  51. CANADA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 67
  52. CANADA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 68
  53. CANADA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 68
  54. CANADA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 69
  55. LATIN AMERICA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 69
  56. LATIN AMERICA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 70
  57. LATIN AMERICA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 70
  58. LATIN AMERICA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 70
  59. LATIN AMERICA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 71
  60. LATIN AMERICA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 71
  61. LATIN AMERICA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 72
  62. EUROPE: CARDIAC IMPLANTS MARKET, BY REGION, 2022–2030 (USD Billion) 73
  63. EUROPE: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 74
  64. EUROPE: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 74
  65. EUROPE: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 75
  66. EUROPE: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 75
  67. EUROPE: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 76
  68. EUROPE: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 76
  69. EUROPE: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 77
  70. WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD Billion) 78
  71. WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 78
  72. WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 79
  73. WESTERN EUROPE: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 79
  74. WESTERN EUROPE: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 79
  75. WESTERN EUROPE: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 80
  76. WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 80
  77. WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 81
  78. GERMANY: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 81
  79. GERMANY: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 82
  80. GERMANY: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 82
  81. GERMANY: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 82
  82. GERMANY: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 83
  83. GERMANY: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 83
  84. GERMANY: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 84
  85. FRANCE: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 84
  86. FRANCE: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 85
  87. FRANCE: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 85
  88. FRANCE: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 85
  89. FRANCE: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 86
  90. FRANCE: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 86
  91. FRANCE: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 87
  92. UK: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 87
  93. UK: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 88
  94. UK: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 88
  95. UK: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 88
  96. UK: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 89
  97. UK: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 89
  98. UK: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 90
  99. ITALY: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 90
  100. ITALY: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 91
  101. ITALY: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 91
  102. ITALY: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 91
  103. ITALY: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 92
  104. ITALY: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 92
  105. ITALY: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 93
  106. SPAIN: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 93
  107. SPAIN: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 94
  108. SPAIN: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 94
  109. SPAIN: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 94
  110. SPAIN: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 95
  111. SPAIN: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 95
  112. SPAIN: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 96
  113. REST OF WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 96
  114. REST OF WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 97
  115. REST OF WESTERN EUROPE: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 97
  116. REST OF WESTERN EUROPE: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 97
  117. REST OF WESTERN EUROPE: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 98
  118. REST OF WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 98
  119. REST OF WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 99
  120. EASTERN EUROPE CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 99
  121. EASTERN EUROPE: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 100
  122. EASTERN EUROPE: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 100
  123. EASTERN EUROPE: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 100
  124. EASTERN EUROPE: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 101
  125. EASTERN EUROPE: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 101
  126. EASTERN EUROPE: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 102
  127. ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022–2030 (USD Billion) 103
  128. ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 104
  129. ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 104
  130. ASIA-PACIFIC: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 105
  131. ASIA-PACIFIC: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 105
  132. ASIA-PACIFIC: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 106
  133. ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 106
  134. ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 107
  135. JAPAN: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 107
  136. JAPAN: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 108
  137. JAPAN: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 108
  138. JAPAN: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 108
  139. JAPAN: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 109
  140. JAPAN: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 109
  141. JAPAN: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 110
  142. CHINA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 110
  143. CHINA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 111
  144. CHINA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 111
  145. CHINA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 111
  146. CHINA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 112
  147. CHINA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 112
  148. CHINA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 113
  149. INDIA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 113
  150. INDIA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 114
  151. INDIA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 114
  152. INDIA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 114
  153. INDIA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 115
  154. INDIA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 115
  155. INDIA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 116
  156. AUSTRALIA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 116
  157. AUSTRALIA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 117
  158. AUSTRALIA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 117
  159. AUSTRALIA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 117
  160. AUSTRALIA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 118
  161. AUSTRALIA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 118
  162. AUSTRALIA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 119
  163. SOUTH KOREA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 119
  164. SOUTH KOREA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 120
  165. SOUTH KOREA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 120
  166. SOUTH KOREA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 120
  167. SOUTH KOREA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 121
  168. SOUTH KOREA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 121
  169. SOUTH KOREA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 122
  170. REST OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 122
  171. REST OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 123
  172. REST OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 123
  173. REST OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 123
  174. REST OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 124
  175. REST OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 124
  176. REST OF ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 125
  177. MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET, BY REGION, 2022–2030 (USD Billion) 126
  178. MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 127
  179. MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 127
  180. MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 128
  181. MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 128
  182. MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 129
  183. MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 129
  184. MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 130
  185. MIDDLE EAST: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 130
  186. MIDDLE EAST: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 131
  187. MIDDLE EAST: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 131
  188. MIDDLE EAST: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 131
  189. MIDDLE EAST: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 132
  190. MIDDLE EAST: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 132
  191. MIDDLE EAST: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 133
  192. AFRICA: CARDIAC IMPLANTS MARKET, BY DEVICE, 2022–2030 (USD Billion) 133
  193. AFRICA: CARDIAC IMPLANTS MARKET, BY CARDIAC RHYTHM MANAGEMENT DEVICES, BY TYPE, 2022–2030 (USD Billion) 134
  194. AFRICA: CARDIAC IMPLANTS MARKET FOR IMPLANTABLE CARDIAC PACEMAKER, BY TYPE, 2022–2030 (USD Billion) 134
  195. AFRICA: CARDIAC IMPLANTS MARKET FOR CORONARY STENTS, BY TYPE, 2022–2030 (USD Billion) 134
  196. AFRICA: CARDIAC IMPLANTS MARKET FOR PROSTHETIC HEART VALVE DEVICES, BY TYPE, 2022–2030 (USD Billion) 135
  197. AFRICA: CARDIAC IMPLANTS MARKET, BY INDICATION, 2022–2030 (USD Billion) 135
  198. AFRICA: CARDIAC IMPLANTS MARKET, BY END USER, 2022–2030 (USD Billion) 136 16 List of Figures
  199. GLOBAL CARDIAC IMPLANTS MARKET: MARKET STRUCTURE 18
  200. RESEARCH PROCESS OF MRFR 20
  201. TOP-DOWN & BOTTOM-UP APPROACHES 23
  202. MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CARDIAC IMPLANTS MARKET 25
  203. VALUE CHAIN: GLOBAL CARDIAC IMPLANTS MARKET 29
  204. PORTER’S FIVE FORCES ANALYSIS: GLOBAL CARDIAC IMPLANTS MARKET 30
  205. GLOBAL CARDIAC IMPLANTS MARKET, BY DEVICE, 2022 AND 2030 (USD Billion) 34
  206. GLOBAL CARDIAC IMPLANTS MARKET SHARE, BY DEVICE, 2022 (%) 34
  207. GLOBAL CARDIAC IMPLANTS MARKET, BY INDICATION, 2022 AND 2030 (USD Billion) 42
  208. GLOBAL CARDIAC IMPLANTS MARKET SHARE, BY INDICATION, 2022 (%) 42
  209. GLOBAL CARDIAC IMPLANTS MARKET, BY END USER, 2022 AND 2030 (USD Billion) 48
  210. GLOBAL CARDIAC IMPLANTS MARKET SHARE, BY END USER, 2022 (%) 48
  211. GLOBAL CARDIAC IMPLANTS MARKET, BY REGION, 2022 AND 2030 (USD Billion) 53
  212. GLOBAL CARDIAC IMPLANTS MARKET SHARE, BY REGION, 2022 (%) 53
  213. AMERICAS: CARDIAC IMPLANTS MARKET, BY REGION, 2022 (%) 55
  214. NORTH AMERICA: CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022 (%) 59
  215. EUROPE: CARDIAC IMPLANTS MARKET, BY REGION, 2022 (%) 73
  216. WESTERN EUROPE: CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022 (%) 77
  217. ASIA-PACIFIC: CARDIAC IMPLANTS MARKET, BY COUNTRY, 2022 (%) 103
  218. MIDDLE EAST & AFRICA: CARDIAC IMPLANTS MARKET, BY REGION, 2022 (%) 126
  219. GLOBAL CARDIAC IMPLANTS MARKET, MARKET SHARE ANALYSIS 2022 (%) 138

Cardiac Implants Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓